Cited by 522Global Cancer Incidence and ScreeningProstate Cancer Diagnosis and TreatmentProstate Cancer Treatment and Research

The DOI matches its Crossref record; 26 of the 28 references it cites were found in a registry or an index.

Global Incidence and Mortality for Prostate Cancer: Analysis of Temporal Patterns and Trends in 36 Countries

Wong, Martin C.S., Goggins, William B., Wang, Harry H.X., Fung, Franklin D.H., Leung, Colette, Wong, Samuel Y.S., Ng, Chi Fai, Sung, Joseph J.Y.·2016·European Urology

DOI 10.1016/j.eururo.2016.05.043

Open this paper in CoChat — free account

Abstract

BACKGROUND: Prostate cancer (PCa) is a leading cause of mortality and morbidity globally, but its specific geographic patterns and temporal trends are under-researched. OBJECTIVE: To test the hypotheses that PCa incidence is higher and PCa mortality is lower in countries with higher socioeconomic development, and that temporal trends for PCa incidence have increased while mortality has decreased over time. DESIGN, SETTING, AND PARTICIPANTS: Data on age-standardized incidence and mortality rates in 2012 were retrieved from the GLOBOCAN database. Temporal patterns were assessed for 36 countries using data obtained from Cancer incidence in five continents volumes I-X and the World Health Organization mortality database. Correlations between incidence or mortality rates and socioeconomic indicators (human development index [HDI] and gross domestic product [GDP]) were evaluated. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The average annual percent change in PCa incidence and mortality in the most recent 10 yr according to join-point regression. RESULTS AND LIMITATIONS: Reported PCa incidence rates varied more than 25-fold worldwide in 2012, with the highest incidence rates observed in Micronesia/Polynesia, the USA, and European countries. Mortality rates paralleled the incidence rates except for Africa, where PCa mortality rates were the highest. Countries with higher HDI (r=0.58) and per capita GDP (r=0.62) reported greater incidence rates. According to the most recent 10-yr temporal data available, most countries experienced increases in incidence, with sharp rises in incidence rates in Asia and Northern and Western Europe. A substantial reduction in mortality rates was reported in most countries, except in some Asian countries and Eastern Europe, where mortality increased. Data in regional registries could be underestimated. CONCLUSIONS: PCa incidence has increased while PCa mortality has decreased in most countries. The reported incidence was higher in countries with higher socioeconomic development. PATIENT SUMMARY: The incidence of prostate cancer has shown high variations geographically and over time, with smaller variations in mortality.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.eururo.2016.05.043

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C. D., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,468
Global patterns and trends in colorectal cancer incidence and mortality
Arnold, M., Sierra, M. S., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2016) · Gut · doi:10.1136/gutjnl-2015-310912 · Cited by 5,392
The United Nations Development Programme
Oestreich, J. E. (2017) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780190637347.003.0003 · Cited by 4,875
Cancer Epidemiology and Prevention
Schottenfeld, D. (2006) · doi:10.1093/acprof:oso/9780195149616.001.0001 · Cited by 3,376
Counting the dead and what they died from: an assessment of the global status of cause of death data.
(2005) · Europe PMC (PubMed Central) · Cited by 1,975
GLOBOCAN 2008 v1.2, Cancer incidence and mortality world-wide : IARC Cancer Base No. 10
Ferlay, J. (2010) · Medical Entomology and Zoology · Cited by 1,636
International Variation in Prostate Cancer Incidence and Mortality Rates
Center, M. M., Jemal, A., Lortet-Tieulent, J., Ward, E., Ferlay, J., Brawley, O., & Bray, F. (2012) · European Urology · doi:10.1016/j.eururo.2012.02.054 · Cited by 1,521
Estimating average annual per cent change in trend analysis
Clegg, L. X., Hankey, B. F., Tiwari, R. C., Feuer, E. J., & Edwards, B. K. (2009) · Statistics in Medicine · doi:10.1002/sim.3733 · Cited by 1,271
International Variation in Female Breast Cancer Incidence and Mortality Rates
Desantis, C. E., Bray, F., Ferlay, J., Lortet‐Tieulent, J., Anderson, B. O., & Jemal, A. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0535 · Cited by 829

Show all 28 references

Sorted by citations

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024) · CA: a cancer journal for clinicians · doi:10.3322/caac.21834 · Cited by 27,064
“…Mortality rates have decreased in most high ‐ income countries since the mid ‐ 1990s, including those in Northern America, Oceania, and Northern and Western Europe, 88,98,100 likely reflecting advancements in effective treatment and earlier detection through increased testing of asymptomatic men.”
Background
Prostate cancer
Rebello, R. J., Oing, C., Knudsen, K. E., Loeb, S., Johnson, D. C., Reiter, R. E., Gillessen, S., van der Kwast, T., & Bristow, R. G. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00243-0 · Cited by 1,238
Worldwide Burden of, Risk Factors for, and Trends in Pancreatic Cancer
Huang, J., Lok, V., Ngai, C. H., Zhang, L., Yuan, J., Lao, X. Q., Ng, K. K., Chong, C. C. N., Zheng, Z., & Wong, M. C. S. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.10.007 · Cited by 539
Self-citation
Cancer incidence and mortality in China, 2013.
Chen, W.-Q., Zheng, R.-S., Zhang, S.-W., Zeng, H., Xia, C., Zuo, T.-T., Yang, Z.-X., Zou, X., & He, J. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.04.024 · Cited by 403
Differences in Incidence and Mortality Trends of Colorectal Cancer Worldwide Based on Sex, Age, and Anatomic Location
Wong, M. C. S., Huang, J., Lok, V., Wang, J., Fung, F. D. H., Ding, H., & Zheng, Z. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.02.026 · Cited by 412
Self-citation
Global Incidence and Mortality of Gastric Cancer, 1980-2018
Wong, M. C. S., Huang, J., Chan, P. S.-F., Choi, P., Lao, X. Q., Chan, S. M., Teoh, A. Y., & Liang, P. S. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.18457 · Cited by 423
Self-citation
Melatonin for the prevention and treatment of cancer
Li, Y., Li, S., Zhou, Y., Meng, X., Zhang, J., Xu, D.-P., & Li, H. (2017) · Oncotarget · doi:10.18632/oncotarget.16379 · Cited by 388
Incidence and mortality of lung cancer: global trends and association with socioeconomic status
Wong, M. C. S., Lao, X. Q., Ho, K., Goggins, W. B., & Tse, S. L. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-14513-7 · Cited by 390
Self-citation
The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection
Wong, M. C. S., Fung, F. D. H., Leung, C., Cheung, W. W. L., Goggins, W. B., & Ng, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-19199-z · Cited by 308
Self-citation
Epidemiology and genomics of prostate cancer in Asian men
Zhu, Y., Mo, M., Yu, W., Wu, J., Pan, J. G., Freedland, S. J., Zheng, Y., & Ye, D. (2021) · Nature Reviews Urology · doi:10.1038/s41585-021-00442-8 · Cited by 293
Recent Patterns and Trends in Global Prostate Cancer Incidence and Mortality: An Update
Schafer, E. J., Laversanne, M., Sung, H., Soerjomataram, I., Briganti, A., Dahut, W. L., Bray, F., & Jemal, A. (2024) · European Urology · doi:10.1016/j.eururo.2024.11.013 · Cited by 283
Global incidence and mortality of breast cancer: a trend analysis
Huang, J., Chan, P. S.-F., Lok, V., Chen, X., Ding, H., Jin, Y., Yuan, J., Lao, X. Q., Zheng, Z., & Wong, M. C. S. (2021) · Aging · doi:10.18632/aging.202502 · Cited by 288
Self-citation
Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression
Xue, C., Li, G., Lü, J., & Li, L. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00788-w · Cited by 266
The global cancer burden and human development: A review
Fidler-Benaoudia, M. M., Bray, F., & Soerjomataram, I. (2017) · Scandinavian Journal of Public Health · doi:10.1177/1403494817715400 · Cited by 264
Global Trends of Bladder Cancer Incidence and Mortality, and Their Associations with Tobacco Use and Gross Domestic Product Per Capita
Teoh, J. Y.-C., Huang, J., Ko, W. Y.-K., Lok, V., Choi, P., Ng, C.-F., Sengupta, S., Mostafid, H., Kamat, A. M., Black, P. C., et al. (2020) · European Urology · doi:10.1016/j.eururo.2020.09.006 · Cited by 257
Self-citation
International incidence and mortality trends of liver cancer: a global profile
Wong, M. C. S., Jiang, J. Y., Goggins, W. B., Liang, M., Fang, Y., Fung, F. D. H., Leung, C., Wang, H., Wong, G. L., Wong, V. W., et al. (2017) · Scientific Reports · doi:10.1038/srep45846 · Cited by 255
Self-citation
Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients
Boyle, H. J., Alibhai, S. M. H., Decoster, L., Efstathiou, E., Fizazi, K. S., Mottet, N., Oudard, S. M., Payne, H. A., Prentice, M., Puts, M. T. E., et al. (2019) · European Journal of Cancer · doi:10.1016/j.ejca.2019.04.031 · Cited by 246
Global Burden, Risk Factors, and Trends of Esophageal Cancer: An Analysis of Cancer Registries from 48 Countries
Huang, J., Koulaouzidis, A., Marlicz, W. M., Lok, V., Chu, C., Ngai, C. H., Zhang, L., Chen, P., Wang, S., Yuan, J., et al. (2021) · Cancers · doi:10.3390/cancers13010141 · Cited by 221
Self-citation
Metabolic Biosynthesis Pathways Identified from Fecal Microbiome Associated with Prostate Cancer
Liss, M. A., White, J. R., Goros, M., Gelfond, J., Leach, R. J., Johnson‐Pais, T. L., Lai, Z., Rourke, E. J., Basler, J. W., Ankerst, D. P., et al. (2018) · European Urology · doi:10.1016/j.eururo.2018.06.033 · Cited by 210
Worldwide trends in cervical cancer incidence and mortality, with predictions for the next 15 years
Lin, S., Gao, K., Gu, S., You, L., Qian, S., Tang, M., Wang, J., Chen, K., & Jin, M. (2021) · Cancer · doi:10.1002/cncr.33795 · Cited by 197
Prostate Cancer in Primary Care
Merriel, S. W., Funston, G., & Hamilton, W. T. (2018) · Advances in Therapy · doi:10.1007/s12325-018-0766-1 · Cited by 173
Robot-assisted and laparoscopic vs open radical prostatectomy in clinically localized prostate cancer: perioperative, functional, and oncological outcomes
Cao, L., Yang, Z., Qi, L., & Chen, M. (2019) · Medicine · doi:10.1097/md.0000000000015770 · Cited by 173
Global temporal patterns of pancreatic cancer and association with socioeconomic development
Wong, M. C. S., Jiang, J. Y., Liang, M., Fang, Y., Yeung, M. S., & Sung, J. J. �. (2017) · Scientific Reports · doi:10.1038/s41598-017-02997-2 · Cited by 167
Self-citation
Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021
Zi, H., Liu, M.-Y., Luo, L.-S., Huang, Q. Y., Luo, P.-C., Luan, H., Huang, J., Wang, D., Wang, Y., Zhang, Y., et al. (2024) · Military Medical Research · doi:10.1186/s40779-024-00569-w · Cited by 163
Active surveillance for prostate cancer: a systematic review of contemporary worldwide practices
Kinsella, N., Helleman, J., Bruinsma, S. M., Carlsson, S., Cahill, D. J., Brown, C. T., & Hemelrijck, M. V. (2018) · Translational Andrology and Urology · doi:10.21037/tau.2017.12.24 · Cited by 158
Claudin-1, A Double-Edged Sword in Cancer
Bhat, A. A., Syed, N., Therachiyil, L., Nisar, S., Hashem, S., Macha, M. A., Yadav, S. K., Krishnankutty, R., Shanmugakonar, M., Al‐Naemi, H. A., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020569 · Cited by 147
Circulating Tumor Cells in Prostate Cancer: From Discovery to Clinical Utility
Pantel, K., Hille, C., & Scher, H. I. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2018.287102 · Cited by 141
Incidence and mortality of kidney cancer: temporal patterns and global trends in 39 countries
Wong, M. C. S., Goggins, W. B., Yip, B. H. K., Fung, F. D. H., Leung, C., Fang, Y., Wong, S. Y. S., & Ng, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-15922-4 · Cited by 136
Self-citation
NOD-like receptors: major players (and targets) in the interface between innate immunity and cancer
Velloso, F. J., Trombetta-Lima, M., Anschau, V., Sogayar, M. C., & Correa, R. G. (2019) · Bioscience Reports · doi:10.1042/bsr20181709 · Cited by 133
Global Incidence and mortality of oesophageal cancer and their correlation with socioeconomic indicators temporal patterns and trends in 41 countries
Wong, M. C. S., Hamilton, W. T., Whiteman, D. C., Jiang, J. Y., Qiao, Y., Fung, F. D. H., Wang, H., Chiu, P. W. Y., Ng, E. K., Wu, J. C. Y., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19819-8 · Cited by 121
Self-citation
A Global Trend Analysis of Kidney Cancer Incidence and Mortality and Their Associations with Smoking, Alcohol Consumption, and Metabolic Syndrome
Huang, J., Leung, D. K.-W., Chan, E. O.-T., Lok, V., Leung, S., Wong, I., Lao, X. Q., Zheng, Z., Chiu, P. K., Ng, C., et al. (2021) · European Urology Focus · doi:10.1016/j.euf.2020.12.020 · Cited by 118
Self-citation
Global incidence of prostate cancer in developing and developed countries with changing age structures
Teoh, J. Y., Hirai, H. W., Ho, M.-W., Chan, F. C. H., Tsoi, K. K. F., & Ng, C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0221775 · Cited by 114
Self-citation
Prostate cancer treatment – China's perspective
Liu, J., Dong, L., Zhu, Y., Dong, B., Sha, J., Zhu, H. H., Pan, J., & Xue, W. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215927 · Cited by 107
Global Burden of Prostate Cancer and Association with Socioeconomic Status, 1990–2019: A Systematic Analysis from the Global Burden of Disease Study
Zhang, W., Cao, G., Wu, F., Wang, Y., Liu, Z., Hu, H., & Xu, K. (2023) · Journal of Epidemiology and Global Health · doi:10.1007/s44197-023-00103-6 · Cited by 115
Prognostic Biomarkers Used for Localised Prostate Cancer Management: A Systematic Review
Lamy, P., Allory, Y., Gauchez, A., Asselain, B. J. R., Beuzeboc, P., de Crémoux, P., Fontugne, J., Georges, A., Hennequin, C., Lehmann‐Che, J., et al. (2017) · European Urology Focus · doi:10.1016/j.euf.2017.02.017 · Cited by 101
Radium 223 dichloride for prostate cancer treatment
Deshayes, E., Roumiguié, M., Thibault, C., Beuzeboc, P., Cachin, F., Hennequin, C., Huglo, D. G., Rozet, F., Kassab‐Chahmi, D., Rébillard, X., et al. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s122417 · Cited by 101
TMPRSS2:ERG Gene Fusions in Prostate Cancer of West African Men and a Meta-Analysis of Racial Differences
Zhou, C. K., Young, D., Yeboah, E. D., Coburn, S. B., Tettey, Y., Biritwum, R. B., Adjei, A. A., Tay, E., Niwa, S., Truelove, A. L., et al. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx235 · Cited by 92
Role and Therapeutic Potential of Melatonin in Various Type of Cancers
Gurunathan, S., Qasim, M. H., Kang, M.-H., & Kim, J. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s298512 · Cited by 92
Disease Burden, Risk Factors, and Recent Trends of Liver Cancer: A Global Country-Level Analysis
Huang, J., Lok, V., Ngai, C. H., Chu, C., Patel, H. K., Chandraseka, V. T., Zhang, L., Chen, P., Wang, S., Lao, X. Q., et al. (2021) · Liver Cancer · doi:10.1159/000515304 · Cited by 92
Self-citation
Deconstructing, Addressing, and Eliminating Racial and Ethnic Inequities in Prostate Cancer Care
Nyame, Y. A., Cooperberg, M. R., Cumberbatch, M. G. K., Eggener, S. E., Etzioni, R., Gomez, S. L., Haiman, C., Huang, F. W., Lee, C. T., Litwin, M. S., et al. (2022) · European Urology · doi:10.1016/j.eururo.2022.03.007 · Cited by 92
Precision surgery and genitourinary cancers
Riccardo Autorino, B., Porpiglia, F., Prokar Dasgupta, A., Rassweiler, J., Catto, J. W. F., Hampton, L. J., Lima, E., Mirone, V. G., Derweesh, I., & Debruyne, F. M. J. (2017) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2017.02.005 · Cited by 85
The Hippo Pathway in Prostate Cancer
Salem, O., & Hansen, C. G. (2019) · Cells · doi:10.3390/cells8040370 · Cited by 89
Prostate cancer screening in Europe and Asia
Zhang, K., Bangma, C. H., & Roobol, M. J. (2016) · Asian journal of urology · doi:10.1016/j.ajur.2016.08.010 · Cited by 82
Worldwide burden and epidemiological trends of tracheal, bronchus, and lung cancer: A population-based study
Zhou, B., Zang, R., Zhang, M., Song, P., Liu, L., Bie, F., Peng, Y., Bai, G., & Gao, S. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103951 · Cited by 82
Rising Prostate Cancer Incidence in Sub-Saharan Africa: A Trend Analysis of Data from the African Cancer Registry Network
Seraphin, T. P., Joko-Fru, W. Y., Kamaté, B., Chokunonga, E., Wabinga, H., Somdyala, N. I. M., Manraj, S. S., Ogunbiyi, O. J., Dzamalala, C. P., Finesse, A., et al. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-1005 · Cited by 80
Prostate cancer screening: Knowledge, attitudes and practices in a sample of men in Italy. A survey
Morlando, M., Pelullo, C. P., & Giuseppe, G. D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186332 · Cited by 79
Role of Calcium Signaling in Prostate Cancer Progression: Effects on Cancer Hallmarks and Bone Metastatic Mechanisms
Ardura, J. A., Álvarez‐Carrión, L., Gutiérrez-Rojas, I., & Alonso, V. (2020) · Cancers · doi:10.3390/cancers12051071 · Cited by 80
Comparison between Briganti, Partin and MSKCC tools in predicting positive lymph nodes in prostate cancer: a systematic review and meta-analysis
Cimino, S., Reale, G., Castelli, T., Favilla, V., Giardina, R., Russo, G. I., Privitera, S., & Morgia, G. (2017) · Scandinavian Journal of Urology · doi:10.1080/21681805.2017.1332680 · Cited by 79
Global incidence, mortality and temporal trends of cancer in children: A joinpoint regression analysis
Huang, J., Chan, S. C., Ngai, C. H., Lok, V., Zhang, L., Lucero‐Prisno, D. E., Xu, W., Zheng, Z., Elcarte, E. S., Withers, M. H., et al. (2022) · Cancer Medicine · doi:10.1002/cam4.5009 · Cited by 75
Self-citation
[68Ga]Ga-PSMA-11 PET imaging as a predictor for absorbed doses in organs at risk and small lesions in [177Lu]Lu-PSMA-617 treatment
Peters, S. M. B., Hofferber, R., Privé, B. M., de Bakker, M., Gotthardt, M., Janssen, M. J. R., de Lange, F., Muselaers, S., Mehra, N., Witjes, J. A., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05538-2 · Cited by 78
Incidence and mortality of thyroid cancer in 50 countries: a joinpoint regression analysis of global trends
Huang, J., Ngai, C. H., Deng, Y., Pun, C. N., Lok, V., Zhang, L., Xu, Q., Lucero‐Prisno, D. E., Xu, W., Zheng, Z., et al. (2023) · Endocrine · doi:10.1007/s12020-022-03274-7 · Cited by 74
Self-citation
LncRNA KCNQ1OT1 sponges miR-15a to promote immune evasion and malignant progression of prostate cancer via up-regulating PD-L1
Chen, Q., Li, B., Liu, D.-G., Zhang, B., Yang, X. Z., & Tu, Y.-L. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01481-8 · Cited by 73
New Challenges in Psycho-Oncology Research III: A systematic review of psychological interventions for prostate cancer survivors and their partners: clinical and research implications
Chambers, S. K., Hyde, M. K., Smith, D. P., Hughes, S., Yuill, S., Egger, S. J., O’Connell, D. L., Stein, K., Frydenberg, M., Wittert, G., et al. (2017) · Psycho-Oncology · doi:10.1002/pon.4431 · Cited by 72
Interactions between life expectancy and the incidence and mortality rates of cancer in China: a population‐based cluster analysis
Gu, X., Zheng, R., Xia, C., Zeng, H., Zhang, S., Zou, X., Yang, Z., He, L., & Chen, W. (2018) · 癌症：英文版 · doi:10.1186/s40880-018-0308-x · Cited by 71
68Ga-PSMA PET/CT for monitoring response to 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer
Heinzel, A., Boghos, D., Mottaghy, F. M., Gaertner, F. C., Essler, M., von Mallek, D., & Ahmadzadehfar, H. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-4258-6 · Cited by 72
Nanoliposomal formulation encapsulating celecoxib and genistein inhibiting COX-2 pathway and Glut-1 receptors to prevent prostate cancer cell proliferation
Tian, J., Guo, F., Chen, Y., Li, Y., Yu, B., & Li, Y. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.01.002 · Cited by 70
Systemic immune-inflammation index is a promising non-invasive biomarker for predicting the survival of urinary system cancers: a systematic review and meta-analysis
Li, X., Gu, L., Chen, Y., Chong, Y., Wang, X., Guo, P., & He, D. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.1991591 · Cited by 68
Cancer Trends in Iraq 2000–2016
Hussain, A. M. A., & Lafta, R. (2021) · Oman Medical Journal · doi:10.5001/omj.2021.18 · Cited by 66
Analytical performance of aPROMISE: automated anatomic contextualization, detection, and quantification of [18F]DCFPyL (PSMA) imaging for standardized reporting
Johnsson, K., Brynolfsson, J., Sahlstedt, H., Nickols, N. G., Rettig, M. B., Probst, S., Morris, M. J., Bjartell, A. S., Eiber, M., & Anand, A. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05497-8 · Cited by 64
Lateral flow assay ruler for quantitative and rapid point-of-care testing
Li, Z., Chen, H., & Wang, P. (2019) · The Analyst · doi:10.1039/c9an00374f · Cited by 64
Circulating miRNAs as non-invasive biomarkers to predict aggressive prostate cancer after radical prostatectomy
Hoey, C., Ahmed, M., Ghiam, A. F., Vesprini, D., Huang, X., Commisso, K., Commisso, A., Ray, J., Fokas, E., Loblaw, D. A., et al. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1920-5 · Cited by 64
The Crosstalk between Prostate Cancer and Microbiota Inflammation: Nutraceutical Products Are Useful to Balance This Interplay?
Crocetto, F., Boccellino, M., Barone, B., Zazzo, E. D., Sciarra, A., Galasso, G., Settembre, G., Quagliuolo, L., Imbimbo, C., Boffo, S., et al. (2020) · Nutrients · doi:10.3390/nu12092648 · Cited by 64
Identification of Potential Key Genes for Pathogenesis and Prognosis in Prostate Cancer by Integrated Analysis of Gene Expression Profiles and the Cancer Genome Atlas
Liu, S., Wang, W., Zhao, Y. F., Liang, K.-G., & Huang, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00809 · Cited by 63
Dietary Carotenoid Intakes and Prostate Cancer Risk: A Case-Control Study from Vietnam
Hoang, D. V., Pham, N. M., Lee, A. H., Tran, D., & Binns, C. W. (2018) · Nutrients · doi:10.3390/nu10010070 · Cited by 63
Pain, fatigue and depression symptom cluster in survivors of prostate cancer
Baden, M., Lu, L., Drummond, F. J., Gavin, A., & Sharp, L. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-019-05268-0 · Cited by 56
Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer: Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 Trial
Ahlgren, G., Flodgren, P., Tammela, T. L. J., Kellokumpu‐Lehtinen, P., Borre, M., Angelsen, A., Iversen, J. R., Sverrisdóttir, Á., Jónsson, E., & Sengeløv, L. (2018) · European Urology · doi:10.1016/j.eururo.2018.01.012 · Cited by 54
Anticancer activity of Salvia officinalis essential oil and its principal constituents against hormone-dependent tumour cells
Privitera, G., Luca, T., Castorina, S., Passanisi, R., Ruberto, G., & Napoli, E. (2019) · Asian Pacific Journal of Tropical Biomedicine · doi:10.4103/2221-1691.250266 · Cited by 55
Green Tea Catechins for Prostate Cancer Prevention: Present Achievements and Future Challenges
Naponelli, V., Ramazzina, I., Lenzi, C., Bettuzzi, S., & Rizzi, F. (2017) · Antioxidants · doi:10.3390/antiox6020026 · Cited by 53
Appraising causal relationships of dietary, nutritional and physical-activity exposures with overall and aggressive prostate cancer: two-sample Mendelian-randomization study based on 79 148 prostate-cancer cases and 61 106 controls
Kazmi, N., Haycock, P., Tsilidis, K. K., Lynch, B. M., Truong, T., CRUK, BPC3, CAPS, PEGASUS, Martin, R. M., et al. (2019) · International Journal of Epidemiology · doi:10.1093/ije/dyz235 · Cited by 51
Night Shift Work, Chronotype, Sleep Duration, and Prostate Cancer Risk: CAPLIFE Study
Lozano‐Lorca, M., Olmedo‐Requena, R., Vega-Galindo, M.-V., Vázquez‐Alonso, F., Jiménez-Pacheco, A., Salcedo‐Bellido, I., Sánchez, M., & Jiménez‐Moleón, J. J. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17176300 · Cited by 51
Clinical Relevance of Circulating Tumor Cells in Prostate Cancer Management
Cieślikowski, W. A., Antczak, A., Nowicki, M. O., Zabel, M., & Budna, J. (2021) · Biomedicines · doi:10.3390/biomedicines9091179 · Cited by 52
Potential role of gut microbiota in prostate cancer: immunity, metabolites, pathways of action?
Zha, C., Peng, Z., Huang, K., Tang, K., Wang, Q., Zhu, L. J., Che, B., Li, W., Xu, S., Huang, T., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1196217 · Cited by 49
Standardized Magnetic Resonance Imaging Reporting Using the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation Criteria and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion with Transperineal Saturation Biopsy to Select Men on Active Surveillance
Dieffenbacher, S., Nyarangi-Dix, J. N., Giganti, F., Bonekamp, D., Kesch, C. V., Wolf, M. B., Schütz, V., Gasch, C., Hatiboglu, G., Hauffe, M., et al. (2019) · European Urology Focus · doi:10.1016/j.euf.2019.03.001 · Cited by 47
Practical considerations for prostate hypofractionation in the developing world
Yan, M., Gouveia, A. G., Cury, F., Moideen, N., Bratti, V. F., Patrocinio, H. J., Berlín, A., Mendez, L. C., & de Moraes, F. Y. (2021) · Nature Reviews Urology · doi:10.1038/s41585-021-00498-6 · Cited by 46
Which clinical and radiological characteristics can predict clinically significant prostate cancer in PI-RADS 3 lesions? A retrospective study in a high-volume academic center
Hermie, I., Besien, J. V., Visschere, P. D., Lumen, N., & Decaestecker, K. (2019) · European Journal of Radiology · doi:10.1016/j.ejrad.2019.02.031 · Cited by 45
Oncogenic ETS Factors in Prostate Cancer
Nicholas, T. R., Strittmatter, B. G., & Hollenhorst, P. C. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-32656-2_18 · Cited by 49
Free Fatty Acids Promote the Development of Prostate Cancer by Upregulating Peroxisome Proliferator-Activated Receptor Gamma
Ha, X., Wang, J., Chen, K., Deng, Y., Zhang, X., Feng, J., Li, X., Zhu, J., Ma, Y., Qiu, T., et al. (2020) · Cancer Management and Research · doi:10.2147/cmar.s236301 · Cited by 44
Retracted
Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression
Kamdar, S. N., Isserlin, R., van der Kwast, T., Zlotta, A. R., Bader, G. D., Fleshner, N. E., & Bapat, B. V. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0651-z · Cited by 44
Benefits of Adopting Hypofractionated Radiotherapy as a Standard of Care in Low-and Middle-Income Countries
Kraus, R., Weil, C. R., & Abdel–Wahab, M. (2022) · JCO Global Oncology · doi:10.1200/go.22.00215 · Cited by 43
Unraveling the Burden of Pancreatic Cancer in the 21st Century: Trends in Incidence, Mortality, Survival, and Key Contributing Factors
Zottl, J., Sebesta, C., Tomosel, E., Sebesta, M. C., & Sebesta, C. (2025) · Cancers · doi:10.3390/cancers17101607 · Cited by 49
Prognostic Role of Preoperative Serum Lipid Levels in Patients Undergoing Radical Prostatectomy for Clinically Localized Prostate Cancer
Wettstein, M. S., Saba, K., Umbehr, M., Murtola, T. J., Fankhauser, C. D., Adank, J., Hofmann, M., Sulser, T., Hermanns, T., Moch, H., et al. (2017) · The Prostate · doi:10.1002/pros.23296 · Cited by 43
Recent advances in prostate cancer research: large-scale genomic analyses reveal novel driver mutations and DNA repair defects
Frank, S. B., Nelson, P. S., & Vasioukhin, V. I. (2018) · F1000Research · doi:10.12688/f1000research.14499.1 · Cited by 45
Prostate cancer survival in sub-Saharan Africa by age, stage at diagnosis, and human development index: a population-based registry study
Seraphin, T. P., Joko-Fru, W. Y., Manraj, S. S., Chokunonga, E., Somdyala, N. I. M., Korir, A., N’Da, G., Finesse, A., Wabinga, H., Assefa, M., et al. (2021) · Cancer Causes & Control · doi:10.1007/s10552-021-01453-x · Cited by 42
Impact of Metabolic Diseases, Drugs, and Dietary Factors on Prostate Cancer Risk, Recurrence, and Survival: A Systematic Review by the European Association of Urology Section of Oncological Urology
Campi, R., Brookman-May, S. D., Subiela, J. D., Akdoğan, B., Brausi, M. A., Klatte, T., Langenhuijsen, J. F., Linares-Espinós, E., Martin Marszalek, A., Morgan Rouprêt, A., et al. (2018) · European Urology Focus · doi:10.1016/j.euf.2018.04.001 · Cited by 42
The Microbiome of Prostate Fluid Is Associated With Prostate Cancer
Ma, X., Chi, C., Fan, L., Dong, B., Shao, X., Xie, S., Li, M., & Xue, W. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01664 · Cited by 42
The establishment of immune infiltration based novel recurrence predicting nomogram in prostate cancer
Meng, J., Liu, Y., Guan, S., Fan, S., Zhou, J., Zhang, M., & Liang, C. Y. (2019) · Cancer Medicine · doi:10.1002/cam4.2433 · Cited by 42
Effects of social support, hope and resilience on depressive symptoms within 18 months after diagnosis of prostate cancer
Zhao, X., Sun, M., & Yang, Y. (2021) · Health and Quality of Life Outcomes · doi:10.1186/s12955-020-01660-1 · Cited by 42
Increased risk of suicide in New South Wales men with prostate cancer: Analysis of linked population-wide data
Smith, D. P., Calopedos, R., Bang, A., Yu, X. Q., Egger, S., Chambers, S., & O’Connell, D. L. (2018) · PLOS ONE · doi:10.1371/journal.pone.0198679 · Cited by 41
The Clinicopathologic and Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1) Expression in Patients With Prostate Cancer: A Systematic Review and Meta-Analysis
Li, Y., Huang, Q., Zhou, Y., He, M., Chen, J., Gao, Y., & Wang, X. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01494 · Cited by 42
Gastric cancer incidence trends in China and Japan from 1990 to 2019: Disentangling age–period–cohort patterns
Li, Y., Ren, N., Zhang, B., Yang, C., Li, A., Li, X., Lei, Z., Fei, L., Fan, S., & Zhang, J. (2022) · Cancer · doi:10.1002/cncr.34511 · Cited by 41
Global burden, risk factors, and trends of non‐Hodgkin lymphoma: A worldwide analysis of cancer registries
Huang, J., Chan, S. C., Lok, V., Zhang, L., Lucero‐Prisno, D. E., Xu, W., Zheng, Z., Elcarte, E. S., Withers, M. H., & Wong, M. C. S. (2024) · Cancer Medicine · doi:10.1002/cam4.7056 · Cited by 41
Self-citation
Benefits of Using Stereotactic Body Radiotherapy in Patients With Metachronous Oligometastases of Hormone-Sensitive Prostate Cancer Detected by [18F]fluoromethylcholine PET/CT
Bouman-Wammes, E. W., Jong, J. M. V. D.-D., Dahele, M. R., Cysouw, M. C. F., Hoekstra, O. S., van Moorselaar, R. J. A., Piet, M., Verberne, H. J., Bins, A. D., Verheul, H. M. W., et al. (2017) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2017.03.009 · Cited by 40
Depression and Prostate Cancer: Examining Comorbidity and Male-Specific Symptoms
Rice, S., Oliffe, J. L., Kelly, M. T., Cormie, P., Chambers, S. K., Ogrodniczuk, J. S., & Kealy, D. (2018) · American Journal of Men s Health · doi:10.1177/1557988318784395 · Cited by 39
Comparison of perioperative outcomes in elderly (age ≧ 75 years) vs. younger men undergoing robot-assisted radical prostatectomy
Yamada, Y., Teshima, T., Fujimura, T., Sato, Y., Nakamura, M., Niimi, A., Kimura, N., Kakutani, S., Kawai, T., Yamada, D., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234113 · Cited by 38
Mitochondrial biology and prostate cancer ethnic disparity
Xiao, J., Cohen, P., Stern, M. C., Odedina, F. T., Carpten, J. D., & Reams, R. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy133 · Cited by 37
Big Medical Data Decision-Making Intelligent System Exploiting Fuzzy Inference Logic for Prostate Cancer in Developing Countries
Liu, K., Chen, Z., Wu, J., Tan, Y., Wang, L., Yan, Y., Zhang, H., & Long, J. (2018) · IEEE Access · doi:10.1109/access.2018.2886198 · Cited by 36
Global Trends of Prostate Cancer by Age, and Their Associations With Gross Domestic Product (GDP), Human Development Index (HDI), Smoking, and Alcohol Drinking
Huang, J., Chan, E. O.-T., Liu, X., Lok, V., Ngai, C. H., Zhang, L., Xu, W., Zheng, Z., Chiu, P. K., Vasdev, N., et al. (2023) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2023.02.003 · Cited by 37
Self-citation
Somatostatin receptor subtype 1 as a potential diagnostic marker and therapeutic target in prostate cancer
Pedraza‐Arévalo, S., Hormaechea‐Agulla, D., Gómez‐Gómez, E., Requena, M. J., Selth, L. A., Gahete, M. D., Castano, J. P., & Luque, R. M. (2017) · The Prostate · doi:10.1002/pros.23426 · Cited by 37

Authors: Wong, M. C. S., Goggins, W. B., Wang, H. H. X., Fung, F. D. H., Leung, C., Wong, S. Y. S., Ng, C. F., & Sung, J. J. Y.
Affiliations: Prince of Wales Hospital (CN)
Chinese University of Hong Kong (HK)
Corresponding author: Sung, Joseph J.Y.
ORCID: Wong, Martin C.S.
Goggins, William B.
Leung, Colette
Wong, Samuel Y.S.
Ng, Chi Fai
Sung, Joseph J.Y.
Venue: European Urology
Publisher: Elsevier BV
Published: 2016-11
Volume: 70
Issue: 5
Pages: 862-874
ISSN: 0302-2838 (ISSN-L)
DOI: 10.1016/j.eururo.2016.05.043
OpenAlex: W2415076046
Cited by: 513
References: 28
Citations by year: 2026: 21 · 2025: 29 · 2024: 46 · 2023: 46 · 2022: 44 · 2021: 66 · 2020: 66 · 2019: 90 · 2018: 55 · 2017: 46 · 2016: 3
FWCI: 34.88
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: European Urology (publishedVersion)
PubMed (publishedVersion)
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
Topics: Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
Keywords: prostate cancer, cancer incidence, cancer mortality, temporal trends, socio-economic development, Human Development Index, gross domestic product, global variation, age-standardized rates, cancer registry
MeSH terms: Adult, Age Factors, Aged, Developing Countries, Female, Humans, Male, Middle Aged, Mortality, Prostatic Neoplasms, Socioeconomic Factors, Global Health, World Health Organization, Incidence, Databases, Factual, Developed Countries

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Global Incidence and Mortality for Prostate Cancer: Analysis of Temporal Patterns and Trends in 36 Countries

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks